[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-411237-105":59,"doc-detail-411237-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-utility-of-caffeine-citrate-as-a-neuroprotectant-in-the-early-life-of-premature-newborns-discussion","The utility of caffeine citrate as a neuroprotectant in the early life of premature newborns - Discussion","","The study investigates the use of caffeine citrate as a neuroprotective strategy during the early life of premature newborns, focusing on outcomes related to development and neurological risk. It summarizes key background points, including the clinical motivation for neuroprotection in this vulnerable population and how caffeine citrate is positioned within early neonatal care. The work reports study-related context, measures, and interpretive considerations for evaluating effectiveness and safety signals.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-utility-of-caffeine-citrate-as-a-neuroprotectant-in-the-early-life-of-premature-newborns-discussion/411237/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-utility-of-caffeine-citrate-as-a-neuroprotectant-in-the-early-life-of-premature-newborns-discussion/411237.png","ImageObject",300,407,{"name":92,"@type":93},"Terk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-28",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the document’s focus regarding caffeine citrate?","Question",{"text":112,"@type":113},"It focuses on using caffeine citrate as a neuroprotectant in the early life of premature newborns and evaluating related outcomes and considerations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is neuroprotection important in premature newborns?",{"text":117,"@type":113},"Because premature newborns face higher neurological risk, so early interventions that may support neurodevelopment are clinically meaningful.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the document structure its discussion?",{"text":121,"@type":113},"It outlines the rationale and background, then presents study-related content and interpretation, culminating in a discussion of implications for early neonatal care.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},411237,1791271721,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","􀀁Y􀀙E 􀀖􀀎􀀝􀀐􀀎w  \n􀀙UB􀀘ISHE 18 D􀀎􀀛􀀎􀀌b􀀎􀀏 2025  \nOI 10.3389/􀀞􀀍􀀎􀀉 .2025.1682903  \n􀀁􀀂􀀃􀀄􀀁􀀂 􀀆􀀇  \n􀀁􀀂􀀃􀀄􀀃 􀀆􀀃􀀇􀀈􀀂􀀄􀀉􀀃􀀊  \n􀀋􀀌􀀍􀀎􀀏􀀐􀀂􀀄 􀀑􀀃􀀄􀀄􀀎􀀒􀀎 􀀓􀀃􀀇􀀉􀀃􀀇􀀊 􀀔􀀇􀀐􀀈􀀎􀀉 􀀕􀀐􀀇􀀒􀀉􀀃􀀌  \n􀀈􀀁􀀉􀀃􀀁􀀊􀀁􀀂 􀀆􀀇  \n􀀖􀀃􀀗􀀄􀀘􀀇 􀀙􀀃􀀄􀀄􀀘 􀀚􀀐􀀈􀀛􀀜􀀊  \n􀀔􀀇􀀐􀀝􀀎􀀏􀀗􀀐􀀈􀀘 􀀃􀀞 􀀑􀀃􀀇􀀇􀀎􀀛􀀈􀀐􀀛 􀀈􀀊 S􀀈􀀃􀀏􀀏􀀗􀀊􀀔􀀇􀀐􀀈􀀎􀀉 S􀀈􀀂􀀈􀀎􀀗  \n􀀓􀀐 Y􀀂􀀇􀀒􀀊  \nS􀀎􀀛􀀃􀀇􀀉 A􀀞fi􀀄􀀐􀀂􀀈􀀎􀀉 􀀙􀀃􀀗􀀍􀀐􀀈􀀂􀀄 􀀃􀀞 D􀀂􀀄􀀐􀀂􀀇 􀀆􀀎􀀉􀀐􀀛􀀂􀀄􀀔􀀇􀀐􀀝􀀎􀀏􀀗􀀐􀀈􀀘􀀊 􀀑􀀜􀀐􀀇􀀂  \nA􀀇􀀒􀀎􀀄􀀂 􀀙􀀃􀀘􀀃􀀗􀀊  \n􀀑􀀃 􀀇􀀈􀀏􀀘 􀀑􀀄􀀐􀀇􀀐􀀛􀀊 􀀑􀀃􀀄􀀃􀀌b􀀐􀀂  \n*􀀋􀀌􀀈􀀈􀀁􀀍􀀎􀀌􀀏􀀂􀀁􀀏􀀋􀀁  \n􀀓􀀂 􀀏􀀎􀀇 􀀁􀀜 􀀇􀀒  \n 􀀄􀀍􀀜 􀀇􀀒@􀀃􀀂k􀀄􀀂􀀇􀀉 .􀀎􀀉􀀈􀀁􀀋􀀁􀀃􀀉􀀁􀀂 09 A 􀀒 􀀗􀀈 2025  \n􀀈􀀁􀀉􀀃􀀍􀀁􀀂 14 N􀀃􀀝􀀎􀀌b􀀎􀀏 2025  \n􀀐􀀋􀀋􀀁􀀎􀀄􀀁􀀂 02 D􀀎􀀛􀀎􀀌b􀀎􀀏 2025  \n􀀎􀀑􀀆􀀒􀀃􀀍􀀓􀀁􀀂 18 D􀀎􀀛􀀎􀀌b􀀎􀀏 2025  \n􀀋􀀃􀀄􀀐􀀄􀀃􀀌􀀏  \n􀀁􀀜 􀀇􀀒 􀀓􀀊 D 􀀃􀀇􀀒 􀀕 􀀂􀀇􀀉 Ob􀀎􀀐􀀉 􀀖 (2025) T􀀜􀀎􀀈􀀐􀀄􀀐􀀈􀀘 􀀃􀀞 􀀛􀀂􀀞􀀞􀀎􀀐􀀇􀀎 􀀛􀀐􀀈􀀏􀀂􀀈􀀎 􀀂􀀗 􀀂 􀀇􀀎 􀀏􀀃􀀍􀀏􀀃􀀈􀀎􀀛􀀈􀀂􀀇􀀈  \n􀀐􀀇 􀀈􀀜􀀎 􀀎􀀂􀀏􀀄􀀘 􀀄􀀐􀀞􀀎 􀀃􀀞 􀀍􀀏􀀎􀀌􀀂􀀈 􀀏􀀎 􀀇􀀎wb􀀃􀀏􀀇􀀗: 􀀂  \n􀀄􀀐􀀈􀀎􀀏􀀂􀀈 􀀏􀀎 􀀏􀀎􀀝􀀐􀀎w 􀀃􀀞 􀀈􀀜􀀎 􀀎􀀞􀀞􀀎􀀛􀀈􀀗 􀀃􀀇􀀇􀀎 􀀏􀀃􀀉􀀎􀀝􀀎􀀄􀀃􀀍􀀌􀀎􀀇􀀈􀀂􀀄 􀀃 􀀈􀀛􀀃􀀌􀀎􀀗 .  \n􀀚􀀏􀀃􀀇􀀈 . 􀀁􀀎􀀉􀀐􀀂􀀈􀀏 . 13:1682903 .  \n􀀉􀀃􀀐: 10.3389/􀀞􀀍􀀎􀀉 .2025.1682903  \n􀀋􀀌􀀎􀀇􀀈􀀃􀀔􀀓􀀄  \n© 2025 􀀁􀀜 􀀇􀀒􀀊 D 􀀃􀀇􀀒 􀀂􀀇􀀉 Ob􀀎􀀐􀀉 . T􀀜􀀐􀀗 􀀐􀀗 􀀂􀀇􀀃􀀍􀀎􀀇-􀀂􀀛􀀛􀀎􀀗􀀗 􀀂􀀏􀀈􀀐􀀛􀀄􀀎 􀀉􀀐􀀗􀀈􀀏􀀐b 􀀈􀀎􀀉 􀀇􀀉􀀎􀀏 􀀈􀀜􀀎􀀈􀀎􀀏􀀌􀀗 􀀃􀀞 􀀈􀀜􀀎 􀀑􀀏􀀎􀀂􀀈􀀐􀀝􀀎 􀀑􀀃􀀌􀀌􀀃􀀇􀀗 A􀀈􀀈􀀏􀀐b 􀀈􀀐􀀃􀀇􀀓􀀐􀀛􀀎􀀇􀀗􀀎 (􀀑􀀑 BY) . T􀀜􀀎 􀀗􀀎􀀊 􀀉􀀐􀀗􀀈􀀏􀀐b 􀀈􀀐􀀃􀀇 􀀃􀀏􀀏􀀎􀀍􀀏􀀃􀀉 􀀛􀀈􀀐􀀃􀀇 􀀐􀀇 􀀃􀀈􀀜􀀎􀀏 􀀞􀀃􀀏 􀀌􀀗 􀀐􀀗 􀀍􀀎􀀏􀀌􀀐􀀈􀀈􀀎􀀉􀀊􀀍􀀏􀀃􀀝􀀐􀀉􀀎􀀉 􀀈􀀜􀀎 􀀃􀀏􀀐􀀒􀀐􀀇􀀂􀀄 􀀂 􀀈􀀜􀀃􀀏(􀀗) 􀀂􀀇􀀉 􀀈􀀜􀀎􀀛􀀃􀀍􀀘􀀏􀀐􀀒􀀜􀀈 􀀃w􀀇􀀎􀀏(􀀗) 􀀂􀀏􀀎 􀀛􀀏􀀎􀀉􀀐􀀈􀀎􀀉 􀀂􀀇􀀉 􀀈􀀜􀀂􀀈 􀀈􀀜􀀎􀀃􀀏􀀐􀀒􀀐􀀇􀀂􀀄 􀀍 b􀀄􀀐􀀛􀀂􀀈􀀐􀀃􀀇 􀀐􀀇 􀀈􀀜􀀐􀀗 j􀀃 􀀏􀀇􀀂􀀄 􀀐􀀗 􀀛􀀐􀀈􀀎􀀉􀀊 􀀐􀀇􀀂􀀛􀀛􀀃􀀏􀀉􀀂􀀇􀀛􀀎 w􀀐􀀈􀀜 􀀂􀀛􀀛􀀎􀀍􀀈􀀎􀀉 􀀂􀀛􀀂􀀉􀀎􀀌􀀐􀀛 􀀍􀀏􀀂􀀛􀀈􀀐􀀛􀀎 . N􀀃 􀀗􀀎􀀊 􀀉􀀐􀀗􀀈􀀏􀀐b 􀀈􀀐􀀃􀀇 􀀃􀀏 􀀏􀀎􀀍􀀏􀀃􀀉 􀀛􀀈􀀐􀀃􀀇 􀀐􀀗􀀍􀀎􀀏􀀌􀀐􀀈􀀈􀀎􀀉 w􀀜􀀐􀀛􀀜 􀀉􀀃􀀎􀀗 􀀇􀀃􀀈 􀀛􀀃􀀌􀀍􀀄􀀘 w􀀐􀀈􀀜 􀀈􀀜􀀎􀀗􀀎􀀈􀀎􀀏􀀌􀀗 .  \n􀀁􀀂􀀃 􀀅􀀆􀀇􀀈􀀇􀀆􀀉 􀀊􀀋 􀀌􀀍􀀋􀀋􀀃􀀇􀀎􀀃 􀀌􀀇􀀆􀀏􀀍􀀆􀀃 􀀍􀀐 􀀍􀀎􀀃􀀅􀀏􀀊􀀑􀀏􀀊􀀆􀀃􀀌􀀆􀀍􀀎􀀆 􀀇􀀎 􀀆􀀂􀀃 􀀃􀀍􀀏􀀈􀀉 􀀈􀀇􀀋􀀃􀀊􀀋 􀀑􀀏􀀃􀀒􀀍􀀆􀀅􀀏􀀃 􀀎􀀃􀀓􀀔􀀊􀀏􀀎􀀐􀀕 􀀍􀀈􀀇􀀆􀀃􀀏􀀍􀀆􀀅􀀏􀀃 􀀏􀀃􀀖􀀇􀀃􀀓 􀀊􀀋 􀀆􀀂􀀃 􀀃􀀋􀀋􀀃􀀌􀀆􀀐 􀀊􀀎􀀎􀀃􀀅􀀏􀀊􀀗􀀃􀀖􀀃􀀈􀀊􀀑􀀒􀀃􀀎􀀆􀀍􀀈 􀀊􀀅􀀆􀀌􀀊􀀒􀀃􀀐  \n􀀘􀀍􀀅􀀏􀀃􀀎 􀀙􀀂􀀅􀀎􀀚 􀀛􀀜􀀝 􀀞􀀍􀀇􀀆􀀂􀀈􀀉􀀎 􀀅􀀊􀀎􀀚 􀀛 􀀍􀀎􀀗 R􀀍􀀓􀀍􀀗 O􀀔􀀃􀀇􀀗 􀀛􀀝2  \n1O􀀂k􀀄􀀂􀀇􀀉 􀀔􀀇􀀐􀀝􀀎􀀏􀀗􀀐􀀈􀀘 W􀀐􀀄􀀄􀀐􀀂􀀌 B􀀎􀀂 􀀌􀀃􀀇􀀈 S􀀛􀀜􀀃􀀃􀀄 􀀃􀀞 􀀆􀀎􀀉􀀐􀀛􀀐􀀇􀀎􀀊 􀀖􀀃􀀛􀀜􀀎􀀗􀀈􀀎􀀏􀀊 􀀆􀀋􀀊 􀀔􀀇􀀐􀀈􀀎􀀉 S􀀈􀀂􀀈􀀎􀀗􀀊 2 D􀀎􀀍􀀂􀀏􀀈􀀌􀀎􀀇􀀈􀀃􀀞 􀀁􀀎􀀉􀀐􀀂􀀈􀀏􀀐􀀛􀀗􀀊 D􀀐􀀝􀀐􀀗􀀐􀀃􀀇 􀀃􀀞 􀀁􀀎􀀉􀀐􀀂􀀈􀀏􀀐􀀛 N􀀎 􀀏􀀃􀀄􀀃􀀒􀀘􀀊 􀀑􀀃􀀏􀀎w􀀎􀀄􀀄 􀀙􀀎􀀂􀀄􀀈􀀜 􀀑􀀜􀀐􀀄􀀉􀀏􀀎􀀇’􀀗 􀀙􀀃􀀗􀀍􀀐􀀈􀀂􀀄􀀊 􀀖􀀃􀀘􀀂􀀄 O􀀂k􀀊 􀀆􀀋􀀊􀀔􀀇􀀐􀀈􀀎􀀉 S􀀈􀀂􀀈􀀎􀀗  \nT􀀜􀀎 􀀐􀀇􀀛􀀐􀀉􀀎􀀇􀀛􀀎 􀀃􀀞 􀀍􀀏􀀎􀀌􀀂􀀈 􀀏􀀐􀀈􀀘-􀀏􀀎􀀄􀀂􀀈􀀎􀀉 􀀛􀀃􀀌􀀍􀀄􀀐􀀛􀀂􀀈􀀐􀀃􀀇􀀗 􀀜􀀂􀀗 􀀉􀀎􀀛􀀏􀀎􀀂􀀗􀀎􀀉 􀀉 􀀎 􀀈􀀃􀀂􀀉􀀝􀀂􀀇􀀛􀀎􀀌􀀎􀀇􀀈􀀗 􀀐􀀇 􀀌􀀎􀀉􀀐􀀛􀀂􀀄 􀀍􀀏􀀎􀀝􀀎􀀇􀀈􀀐􀀝􀀎 􀀂􀀇􀀉 􀀗 􀀍􀀍􀀃􀀏􀀈􀀐􀀝􀀎 􀀌􀀎􀀂􀀗 􀀏􀀎􀀗􀀊 b 􀀈 􀀈􀀜􀀎 􀀏􀀂􀀈􀀎 􀀃􀀞􀀇􀀎 􀀏􀀃􀀉􀀎􀀝􀀎􀀄􀀃􀀍􀀌􀀎􀀇􀀈􀀂􀀄 􀀐􀀌􀀍􀀂􀀐􀀏􀀌􀀎􀀇􀀈 􀀗􀀎􀀛􀀃􀀇􀀉􀀂􀀏􀀘 􀀈􀀃 􀀍􀀏􀀎􀀌􀀂􀀈 􀀏􀀐􀀈􀀘 􀀛􀀃􀀇􀀈􀀐􀀇 􀀎􀀗 􀀈􀀃 􀀐􀀇􀀛􀀏􀀎􀀂􀀗􀀎 . D 􀀎 􀀈􀀃 􀀈􀀜􀀎 􀀜􀀐􀀒􀀜 􀀌􀀎􀀈􀀂b􀀃􀀄􀀐􀀛 􀀉􀀎􀀌􀀂􀀇􀀉 􀀃􀀞 􀀈􀀜􀀎 􀀛􀀎􀀇􀀈􀀏􀀂􀀄 􀀇􀀎􀀏􀀝􀀃 􀀗 􀀗􀀘􀀗􀀈􀀎􀀌 􀀉 􀀏􀀐􀀇􀀒 􀀎􀀂􀀏􀀄􀀘􀀉􀀎􀀝􀀎􀀄􀀃􀀍􀀌􀀎􀀇􀀈 􀀂􀀇􀀉 􀀈􀀜􀀎 􀀂􀀒􀀎-􀀏􀀎􀀄􀀂􀀈􀀎􀀉 􀀗􀀎􀀇􀀗􀀐􀀈􀀐􀀝􀀐􀀈􀀘 􀀃􀀞 􀀈􀀜􀀎 􀀛􀀎􀀏􀀎b􀀏􀀂􀀄 w􀀜􀀐􀀈􀀎 􀀌􀀂􀀈􀀈􀀎􀀏􀀊􀀍􀀎􀀏􀀐􀀇􀀂􀀈􀀂􀀄 􀀐􀀇􀀈􀀎􀀏􀀌􀀐􀀈􀀈􀀎􀀇􀀈 􀀜􀀘􀀍􀀃x􀀐􀀂 􀀛􀀂􀀇 􀀄􀀎􀀂􀀉 􀀈􀀃 􀀗􀀐􀀒􀀇􀀐fi􀀛􀀂􀀇􀀈 􀀛􀀎􀀏􀀎b􀀏􀀂􀀄 􀀍􀀂􀀈􀀜􀀃􀀄􀀃􀀒􀀘 􀀍􀀎􀀏􀀗􀀐􀀗􀀈􀀐􀀇􀀒􀀐􀀇􀀈􀀃 􀀂􀀉 􀀄􀀈􀀜􀀃􀀃􀀉 . 􀀑􀀂􀀞􀀞􀀎􀀐􀀇􀀎 􀀛􀀐􀀈􀀏􀀂􀀈􀀎 􀀐􀀗 􀀃􀀇􀀎 􀀃􀀞 􀀈􀀜􀀎 􀀌􀀂􀀐􀀇􀀗􀀈􀀂􀀘 􀀌􀀎􀀉􀀐􀀛􀀂􀀄 􀀈􀀏􀀎􀀂􀀈􀀌􀀎􀀇􀀈􀀗􀀞􀀃􀀏 􀀂􀀍􀀇􀀎􀀂 􀀃􀀞 􀀍􀀏􀀎􀀌􀀂􀀈 􀀏􀀐􀀈􀀘 􀀂􀀇􀀉 􀀐􀀗 w􀀐􀀉􀀎􀀄􀀘 􀀗􀀎􀀉 􀀐􀀇 􀀌􀀂􀀇􀀘 􀀇􀀎􀀃􀀇􀀂􀀈􀀂􀀄 􀀐􀀇􀀈􀀎􀀇􀀗􀀐􀀝􀀎 􀀛􀀂􀀏􀀎􀀇􀀐􀀈􀀗 . 􀀑􀀂􀀞􀀞􀀎􀀐􀀇􀀎 􀀛􀀐􀀈􀀏􀀂􀀈􀀎’􀀗 b􀀎􀀇􀀎fi􀀈􀀗 􀀐􀀇􀀛􀀄 􀀉􀀎 􀀏􀀎􀀉 􀀛􀀐􀀇􀀒 􀀈􀀐􀀌􀀎 􀀃􀀇 􀀌􀀎􀀛􀀜􀀂􀀇􀀐􀀛􀀂􀀄􀀝􀀎􀀇􀀈􀀐􀀄􀀂􀀈􀀐􀀃􀀇􀀊 􀀎􀀇􀀜􀀂􀀇􀀛􀀐􀀇􀀒 􀀎x􀀈 b􀀂􀀈􀀐􀀃􀀇 􀀗 􀀛􀀛􀀎􀀗􀀗􀀊 􀀂􀀇􀀉 􀀉􀀎􀀛􀀏􀀎􀀂􀀗􀀐􀀇􀀒 􀀈􀀜􀀎 􀀐􀀇􀀛􀀐􀀉􀀎􀀇􀀛􀀎 􀀃􀀞 b􀀏􀀃􀀇􀀛􀀜􀀃􀀍 􀀄􀀌􀀃􀀇􀀂􀀏􀀘 􀀉􀀘􀀗􀀍􀀄􀀂􀀗􀀐􀀂 . T􀀜􀀎􀀏􀀎 􀀐􀀗 􀀂􀀄􀀗􀀃 􀀌􀀃 􀀇􀀈􀀐􀀇􀀒 􀀎􀀝􀀐􀀉􀀎􀀇􀀛􀀎 􀀈􀀜􀀂􀀈 􀀛􀀂􀀞􀀞􀀎􀀐􀀇􀀎􀀛􀀐􀀈􀀏􀀂􀀈􀀎 b􀀎􀀇􀀎fi􀀈􀀗 􀀇􀀎 􀀏􀀃􀀉􀀎􀀝􀀎􀀄􀀃􀀍􀀌􀀎􀀇􀀈􀀂􀀄 􀀃 􀀈􀀛􀀃􀀌􀀎􀀗􀀊 􀀂􀀈􀀈􀀏􀀐b 􀀈􀀂b􀀄􀀎 􀀈􀀃 􀀐􀀈􀀗 􀀍􀀃􀀗􀀐􀀈􀀐􀀝􀀎 􀀎􀀞􀀞􀀎􀀛􀀈􀀃􀀇 􀀏􀀎􀀗􀀍􀀐􀀏􀀂􀀈􀀃􀀏􀀘 􀀗􀀈􀀂􀀈 􀀗 􀀂􀀇􀀉 􀀃􀀈􀀜􀀎􀀏 􀀌􀀎􀀛􀀜􀀂􀀇􀀐􀀗􀀌􀀗 . 􀀖􀀎􀀗􀀎􀀂􀀏􀀛􀀜 􀀜􀀂􀀗 􀀗􀀜􀀃w􀀇 􀀈􀀜􀀂􀀈 􀀛􀀂􀀞􀀞􀀎􀀐􀀇􀀎􀀛􀀐􀀈􀀏􀀂􀀈􀀎 􀀎x􀀎􀀏􀀈􀀗 􀀂􀀇 􀀂􀀇􀀈􀀐-􀀐􀀇fl􀀂􀀌􀀌􀀂􀀈􀀃􀀏􀀘 􀀎􀀞􀀞􀀎􀀛􀀈 􀀝􀀐􀀂 􀀈􀀜􀀎 􀀂􀀇􀀈􀀂􀀒􀀃􀀇􀀐􀀗􀀌 􀀃􀀞 􀀂􀀉􀀎􀀇􀀃􀀗􀀐􀀇􀀎􀀏􀀎􀀛􀀎􀀍􀀈􀀃􀀏􀀗􀀊 􀀏􀀎􀀉 􀀛􀀎􀀗 􀀈􀀜􀀎 􀀍􀀏􀀃􀀉 􀀛􀀈􀀐􀀃􀀇 􀀃􀀞 􀀏􀀎􀀂􀀛􀀈􀀐􀀝􀀎 􀀃x􀀘􀀒􀀎􀀇 􀀗􀀍􀀎􀀛􀀐􀀎􀀗􀀊 􀀂􀀇􀀉 􀀗 􀀍􀀍􀀃􀀏􀀈􀀗􀀈􀀜􀀎 􀀍􀀄􀀂􀀗􀀈􀀐􀀛􀀐􀀈􀀘 􀀃􀀞 􀀈􀀜􀀎 􀀛􀀎􀀇􀀈􀀏􀀂􀀄 􀀇􀀎􀀏􀀝􀀃 􀀗 􀀗􀀘􀀗􀀈􀀎􀀌 . T􀀜􀀐􀀗 􀀂􀀏􀀈􀀐􀀛􀀄􀀎 􀀂􀀐􀀌􀀗 􀀈􀀃 􀀏􀀎􀀝􀀐􀀎w 􀀈􀀜􀀎 􀀌􀀃􀀗􀀈  \n􀀍-􀀈􀀃-􀀉􀀂􀀈􀀎 􀀎􀀝􀀐􀀉􀀎􀀇􀀛􀀎 􀀃􀀇 􀀛􀀂􀀞􀀞􀀎􀀐􀀇􀀎 􀀛􀀐􀀈􀀏􀀂􀀈􀀎’􀀗 􀀎􀀞􀀞􀀎􀀛􀀈􀀗 􀀃􀀇 􀀇􀀎 􀀏􀀃􀀍􀀏􀀃􀀈􀀎􀀛􀀈􀀐􀀃􀀇 􀀂􀀇􀀉 􀀐􀀈􀀗 􀀏􀀃􀀄􀀎􀀐􀀇 􀀏􀀎􀀉 􀀛􀀐􀀇􀀒 􀀈􀀜􀀎 􀀗􀀎􀀝􀀎􀀏􀀐􀀈􀀘 􀀃􀀞 􀀇􀀎 􀀏􀀃􀀉􀀎􀀝􀀎􀀄􀀃􀀍􀀌􀀎􀀇􀀈􀀂􀀄 􀀐􀀌􀀍􀀂􀀐􀀏􀀌􀀎􀀇􀀈 􀀂􀀗􀀗􀀃􀀛􀀐􀀂􀀈􀀎􀀉 w􀀐􀀈􀀜 􀀍􀀏􀀎􀀌􀀂􀀈 􀀏􀀐􀀈􀀘 .  \n􀀕􀀁􀀇􀀊􀀌􀀈􀀂􀀍  \n􀀖􀀗􀀘􀀘􀀙􀀚􀀛􀀙􀀜 􀀝􀀞􀀙 􀀙􀀞m 􀀚􀀛􀀘􀀗􀀛 s􀀜 b􀀞􀀗􀀚􀀛 m􀀗g􀀛􀀙 􀀚􀀖 􀀞􀀙so􀀛􀀗􀀛􀀖􀀙 􀀚m􀀗g􀀚􀀛g􀀜 􀀛􀀙u􀀞o􀀝􀀞o 􀀙􀀖 􀀚o􀀛􀀜 ul 􀀞􀀗sou􀀛d  \nI􀀎􀀆􀀏􀀊􀀗􀀅􀀌􀀆􀀇􀀊􀀎  \n􀀁􀀂􀀃 􀀅􀀃􀀆􀀂􀀇􀀈􀀉􀀊􀀋􀀆􀀂􀀌􀀋􀀃 􀀍􀀃􀀎􀀌􀀏􀀊􀀆􀀌􀀏􀀃􀀐􀀑 􀀈􀀌􀀒􀀃 􀀓􀀊􀀔􀀔􀀃􀀌􀀋􀀃 􀀓􀀌􀀆􀀎􀀊􀀆􀀃 􀀕􀀖􀀖􀀗􀀑 􀀂􀀊􀀏􀀃 􀀘􀀃􀀃􀀋 􀀒􀀋􀀙􀀚􀀋 􀀂􀀌􀀐􀀆􀀙􀀎􀀌􀀓􀀊􀀈􀀈􀀇􀀔􀀙􀀎 􀀆􀀂􀀃􀀌􀀎 􀀅􀀃􀀍􀀌􀀓􀀌􀀋􀀊􀀈 􀀛􀀐􀀃􀀑 􀀃􀀐􀀜􀀃􀀓􀀌􀀊􀀈􀀈􀀇 􀀊􀀐 􀀐􀀆􀀌􀀅􀀛􀀈􀀊􀀋􀀆􀀐 􀀔􀀙􀀎 􀀆􀀂􀀃 􀀓􀀃􀀋􀀆􀀎􀀊􀀈 􀀋􀀃􀀎􀀏􀀙􀀛􀀐 􀀐􀀇􀀐􀀆􀀃􀀅􀀝 􀀞􀀋􀀃 􀀙􀀔 􀀆􀀂􀀃􀀌􀀎􀀓􀀙􀀅􀀅􀀙􀀋 􀀛􀀐􀀃􀀐 􀀌􀀋 􀀜􀀃􀀍􀀌􀀊􀀆􀀎􀀌􀀓􀀐 􀀌􀀐 􀀔􀀙􀀎 􀀊􀀜􀀋􀀃􀀊 􀀙􀀔 􀀜􀀎􀀃􀀅􀀊􀀆􀀛􀀎􀀌􀀆􀀇􀀝 􀀜􀀋􀀃􀀊 􀀙􀀔 􀀜􀀎􀀃􀀅􀀊􀀆􀀛􀀎􀀌􀀆􀀇 􀀌􀀐 􀀍􀀃fi􀀋􀀃􀀍 􀀊􀀐 􀀊􀀋􀀊􀀘􀀎􀀛􀀜􀀆 􀀓􀀃􀀐􀀐􀀊􀀆􀀌􀀙􀀋 􀀙􀀔 􀀎􀀃􀀐􀀜􀀌􀀎􀀊􀀆􀀌􀀙􀀋 􀀈􀀊􀀐􀀆􀀌􀀋g 􀀔􀀙􀀎 20 􀀐 􀀌􀀋 􀀌􀀋􀀔􀀊􀀋􀀆􀀐 􀀚􀀌􀀆􀀂 􀀊 g􀀃􀀐􀀆􀀊􀀆􀀌􀀙􀀋􀀊􀀈 􀀊g􀀃 􀀕G 􀀗 􀀙􀀔 􀀈􀀃􀀐􀀐􀀆􀀂􀀊􀀋 37 􀀚􀀃􀀃􀀒􀀐 􀀕1􀀗􀀝 􀀋 􀀃􀀐􀀆􀀌􀀅􀀊􀀆􀀃􀀍 75􀀑000 􀀐􀀌􀀋g􀀈􀀃􀀆􀀙􀀋 􀀘􀀌􀀎􀀆􀀂􀀐 􀀊􀀎􀀃 􀀜􀀎􀀃􀀆􀀃􀀎􀀅􀀝 􀀖􀀛􀀎􀀎􀀃􀀋􀀆􀀈􀀇􀀑 􀀖􀀖 􀀌􀀐􀀚􀀌􀀍􀀃􀀈􀀇 􀀛􀀐􀀃􀀍 􀀊􀀐 􀀊 􀀐􀀆􀀊􀀋􀀍􀀊􀀎􀀍 􀀙􀀔 􀀓􀀊􀀎􀀃 􀀔􀀙􀀎 􀀆􀀂􀀃 􀀆􀀎􀀃􀀊􀀆􀀅􀀃􀀋􀀆 􀀊􀀋􀀍 􀀜􀀎􀀃􀀏􀀃􀀋􀀆􀀌􀀙􀀋 􀀙􀀔 􀀊􀀜􀀋􀀃􀀊 􀀙􀀔 􀀜􀀎􀀃􀀅􀀊􀀆􀀛􀀎􀀌􀀆􀀇􀀌􀀋 􀀆􀀂􀀃 􀀋􀀃􀀙􀀋􀀊􀀆􀀊􀀈 􀀌􀀋􀀆􀀃􀀋􀀐􀀌􀀏􀀃 􀀓􀀊􀀎􀀃 􀀛􀀋􀀌􀀆 􀀕NI􀀖U􀀗􀀝 H􀀙􀀚􀀃􀀏􀀃􀀎􀀑 􀀖􀀖’􀀐 􀀘􀀃􀀋􀀃fi􀀆􀀐 􀀚􀀃􀀎􀀃 􀀔􀀙􀀛􀀋􀀍 􀀆􀀙 􀀃􀀉􀀆􀀃􀀋􀀍􀀘􀀃􀀇􀀙􀀋􀀍 􀀎􀀃􀀍􀀛􀀓􀀌􀀋g 􀀆􀀂􀀃 􀀌􀀋􀀓􀀌􀀍􀀃􀀋􀀓􀀃 􀀙􀀔 􀀊􀀜􀀋􀀃􀀊 􀀆􀀙 􀀌􀀅􀀜􀀎􀀙􀀏􀀌􀀋g 􀀋􀀃􀀛􀀎􀀙􀀍􀀃􀀏􀀃􀀈􀀙􀀜􀀅􀀃􀀋􀀆􀀊􀀈 􀀙􀀛􀀆􀀓􀀙􀀅􀀃􀀐 􀀕2􀀗􀀝  \nF􀀏􀀊􀀎􀀆􀀇􀀃􀀏􀀐 􀀇􀀎 􀀙􀀃􀀗􀀇􀀍􀀆􀀏􀀇􀀌􀀐 0􀀛 􀀋􀀏􀀊􀀎􀀆􀀇􀀃􀀏􀀐􀀇􀀎 .􀀊􀀏􀀚  \nD􀀛􀀃 􀀆􀀙 􀀌􀀆􀀐 􀀐􀀆􀀎􀀛􀀓􀀆􀀛􀀎􀀃􀀑 􀀖􀀖 􀀊􀀈􀀐􀀙 􀀐􀀃􀀎􀀏􀀃􀀐 􀀊","cbCainzsMSyszBM6","https://ap.wps.com/l/cbCainzsMSyszBM6","pdf",434654,"English","# Abstract\n## Introduction and background\n## Methods and study design\n## Results and interpretation\n## Discussion","[{\"question\":\"What is the document’s focus regarding caffeine citrate?\",\"answer\":\"It focuses on using caffeine citrate as a neuroprotectant in the early life of premature newborns and evaluating related outcomes and considerations.\"},{\"question\":\"Why is neuroprotection important in premature newborns?\",\"answer\":\"Because premature newborns face higher neurological risk, so early interventions that may support neurodevelopment are clinically meaningful.\"},{\"question\":\"How does the document structure its discussion?\",\"answer\":\"It outlines the rationale and background, then presents study-related content and interpretation, culminating in a discussion of implications for early neonatal care.\"}]","The utility of caffeine citrate as a neuroprotectant in the early life of premature newborns - Discussion | PDF",1790587890,15]